You're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Wednesday Cannabis Investors, and welcome to the cannabis newsletter from Benzinga. The goal of this newsletter is to keep you up-to-date on the fast-moving world of cannabis investing. How? By providing super high-quality content directly to your inbox everyday.

For example, today we’re talking about Johnson & Johnson’s game-changing nasal spray containing ketamine.

In addition to this top story, we’ve also got a daily mix news, analysis, regulatory updates, and much more.

If there are any other ways we can make your life easier, please reply to this email to let us know. Also, if you don’t think this will be a valuable daily resource, you can scroll to the bottom to unsubscribe.

TOP STORY

Johnson & Johnson Seeks FDA Approval for Game-Changing Esketamine Nasal Spray

Briefly: In a groundbreaking move, pharmaceutical giant Johnson & Johnson has submitted a request to the FDA for the approval of its esketamine nasal spray, a promising treatment for those battling treatment-resistant depression.

So: What makes esketamine unique, and how could it change the landscape of depression treatment? What are the potential benefits and risks associated with this new therapy? As we await the FDA's decision, the medical community and patients alike are buzzing with anticipation.

Why It Matters: This innovative therapy has the potential to revolutionize mental health care, offering hope to millions who have not found relief with traditional treatments.

Dive into our detailed analysis to explore the potential impacts of this cutting-edge treatment and what it means for the future of mental health.

PRESENTED BY BAYMEDICA

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

With society’s growing acceptance of cannabis consumption, a segment that has risen in popularity is edibles, which are simply products containing cannabinoids that one can eat or drink. While edibles containing cannabinoid compounds, such as THC (tetrahydrocannabinol), which induces a euphoric feeling, or CBD (cannabidiol), which has therapeutic attributes, are familiar to many, edibles containing minor cannabinoids are gaining traction among consumers due to the compound’s unique properties and potential health benefits. As such, the minor cannabinoid-infused edibles market stands at the precipice of remarkable growth, fueled by discernible shifts in consumer behavior.

As a stakeholder in this industry transformation, BayMedica continues to focus on scaling its operations and expanding its product offerings to meet the growing demand for high-quality cannabinoids in various applications that may be used by a growing customer base.

Click here for more info.

ZINGERS

$58M Merger: Chain Bridge I Acquires Cannabinoid Medicines Innovator, Eyes Nasdaq Listing

Promising Results In Medical Cannabis: CannaMore's Successful Phase 2a Trial For Colitis Treatment

Czech Republic Continues To Push Toward Marijuana Legalization, Will Save Billions In Cannabis Prosecutions

Shadow-Banned By Retailers, Iowa Beverage Manufacturers Sue State Regulators Over New THC Law

Here's Where To Buy Legal Weed: Snoop Dogg's LA Store And New Cannabis Shops In PA & MT

ONE MORE FOR THE ROAD

Kamala Harris' VP Picks: A Pro-Cannabis Lineup?

Briefly: As speculation swirls around Kamala Harris’ potential vice-presidential picks, one common thread is emerging: strong support for cannabis legalization.

So: With five names in the mix, the political landscape could be set for a significant shift in cannabis policy.

Why It Matters: Who are these potential candidates, and what are their views on cannabis reform? How might their selection influence the broader push for legalization? As the nation watches closely, the stakes have never been higher for cannabis advocates and opponents alike.

Explore the profiles of these prospective VP picks and the potential impact of their pro-cannabis stance. Get the inside scoop and stay ahead of the political curve by reading more.

PRESENTED BY CANNABIS CAPITAL CONFERENCE

Join us on October 8th and 9th in Chicago for the world's largest gathering of cannabis investors - happening just ONE month before the Presidential election.

Get your tickets now by following this link, and access a 20% discount using the code JAVI20.

Get your tickets now on bzcannabis.com – Prices will increase very soon!

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.